EFX vs EOLS · P/E 54, rev $5.68B vs rev $266.3M
Equifax Inc (EFX) versus Evolus Inc (EOLS) — a side-by-side from cached financials, not a winner call.
Equifax Inc (EFX) is a consulting services company listed on US.
Evolus Inc (EOLS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported EFX revenue for 2024-12-31 was $5.68B. Net income was $607.3M. Revenue was up 7.9% from 2023-12-31 to 2024-12-31. EFX currently screens at market cap $33.00B and trailing P/E 54.0.
Latest reported EOLS revenue for 2024-12-31 was $266.3M. Net income was -$50.4M. Revenue was up 31.8% from 2023-12-31 to 2024-12-31. EOLS currently screens at market cap $597.0M.
EFX currently screens at market cap $33.00B and trailing P/E 54.0. EOLS currently screens at market cap $597.0M.
Not investment advice. Open the EFX and EOLS stock pages for the full models.
Not investment advice.